Keywords: Anticancer Drugs, Ca Ix, Ca Xii, Carbonic Anhydrase, Coumarin, Hypoxia, Sulfamate, Sulfamide, Sulfonamide, Thiocoumarin, Carbonate Dehydratase Inhibitor, Carbonate Dehydratase Ix Inhibitor, Unclassified Drug, Antineoplastic Activity, Cancer Inhibition, Drug Potency, Drug Selectivity, Enzyme Inhibition, Human, Review, Structure Activity Relation, Animals, Antigens, Antineoplastic Agents, Carbonic Anhydrase Inhibitors, Disease Progression, Drug Design, Patents As Topic,
Affiliations: *** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy
Università Degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Via della Lastruccia 3, I-50019 Sesto Fiorentino (Firenze), Italy
References: Alterio, V., Di Fiore, A., D'Ambrosio, K., Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? (2012) Chem Rev, 112, pp. 4421-446
Supuran, C., Carbonic anhydrases: Catalytic and inhibition mechanisms distribution and physiological roles (2004) Carbonic Anhydrase: Its Inhibitors and Activators, pp. 1-23. , Supuran CT Scozzafava A Conway J editors CRC Press, Boca Raton, FL
Supuran, C.T., Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181
Guler, O.O., De Simone, G., Supuran, C.T., Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (2010) Curr Med Chem, 17, pp. 1516-1526
Pastoreková, S., Pastorek, J., Cancer-related carbonic anhydrase isoenzymes and their inhibition (2004) Carbonic Anhydrase: Its Inhibitors and Activators, pp. 255-281. , Supuran CT Scozzafava A Conway J editors CRC Press, Boca Raton, FL
Ivanov, S., Liao, S.Y., Ivanova, A., Expression of hypoxia-inducible cellsurface transmembrane carbonic anhydrases in human cancer (2001) Am J Pathol, 158, pp. 905-919
Pastorekova, S., Zatovicova, M., Pastorek, J., Cancer-associated carbonic anhydrases and their inhibition (2008) Curr Pharm des, 14, pp. 685-698
Supuran, C.T., Di Fiore, A., Alterio, V., Recent advances in structural studies of the carbonic anhydrase family: The crystal structure of human CA IX and CA XIII (2010) Curr Pharm des, 16, pp. 3246-3254
Stillebroer, A.B., Mulders, P.F., Boerman, O.C., Carbonic anhydrase IX in renal cell carcinoma: Implications for prognosis, diagnosis, and therapy (2010) Eur Urol, 58, pp. 75-83
Monti, S.M., Supuran, C.T., De Simone, G., Carbonic anhydrase IX as a target for designing novel anticancer drugs (2012) Curr Med Chem, 19, pp. 821-830
Opavský, R., Pastoreková, S., Zelńk, V., Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships (1996) Genomics, 33, pp. 480-487
Pastorek, J., Pastoreková, S., Callebaut, I., Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment (1994) Oncogene, 9, pp. 2877-2888
Wykoff, C.C., Beasley, N.J., Watson, P.H., Hypoxia-inducible expression of tumor-associated carbonic anhydrases (2000) Cancer Res, 60, pp. 7075-7083
Potter, C., Harris, A.L., Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target (2004) Cell Cycle, 3, pp. 164-167
Pastorekova, S., Barathova, M., Kopacek, J., Pastorek, J., Carbonic anhydrase inhibitors targeting cancer: Therapeutic immunologic and diagnostic tools targeting isoforms IX and XII (2009) Drug Design of Zinc-enzyme Inhibitors: Functional Structural and Disease Applications, pp. 193-222. , Supuran CT Winum JY editors Hoboken Wiley New Jersey
Swietach, P., Vaughan-Jones, R.D., Harris, A.L., Regulation of tumor pH and the role of carbonic anhydrase (2007) Cancer Metastasis Rev, 26, pp. 299-310
Stubbs, M., McSheehy, P.M., Griffiths, J.R., Bashford, C.L., Causes and consequences of tumor acidity and implications for treatment (2000) Mol Med Today, 6, pp. 15-19
Helmlinger, G., Sckell, A., Dellian, M., Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism (2002) Clin Cancer Res, 8, pp. 1284-1291
Fukumura, D., Jain, R.K., Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize (2007) J Cell Biochem, 101, pp. 937-949
Lee, A.H., Tannock, I.F., Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells (1998) Cancer Res, 58, pp. 1901-1908
Chiche, J., Brahimi-Horn, M.C., Pouysségur, J., Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer (2010) J Cell Mol Med, 14, pp. 771-794
Svastova, E., Zilka, N., Zat'Ovicova, M., Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin (2003) Exp Cell Res, 290, pp. 332-345
Zavadova, Z., Zavada, J., Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment (2005) Oncol Rep, 13, pp. 977-982
Zavada, J., Zavadova, Z., Pastorek, J., Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion (2000) Br J Cancer, 82, pp. 1808-1813
Innocenti, A., Pastorekova, S., Pastorek, J., The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as an intrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors (2009) Bioorg Med Chem Lett, 19, pp. 5825-5828
Alterio, V., Hilvo, M., Di Fiore, A., Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (2009) Proc Natl Acad Sci USA, 106, pp. 16233-16238
Ditte, P., Dequiedt, F., Svastova, E., Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors (2011) Cancer Res, 71, pp. 7558-7567
Dorai, T., Sawczuk, I.S., Pastorek, J., The role of carbonic anhydrase IX overexpression in kidney cancer (2005) Eur J Cancer, 41, pp. 2935-2947
Hulikova, A., Zatovicova, M., Svastova, E., Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX (2009) FEBS Lett, 583, pp. 3563-3568
Buanne, P., Renzone, G., Monteleone, F., Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells (2013) J Proteome Res, 12, pp. 282-292
Hilvo, M., Baranauskiene, L., Salzano, A.M., Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes (2008) J Biol Chem, 283, pp. 27799-27809
Türeci, O., Sahin, U., Vollmar, E., Human carbonic anhydrase XII: CDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers (1998) Proc Natl Acad Sci USA, 95, pp. 7608-7613
Ivanov, S.V., Kuzmin, I., Wei, M.H., Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes (1998) Proc Natl Acad Sci USA, 95, pp. 12596-12601
Hynninen, P., Vaskivuo, L., Saarnio, J., Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours (2006) Histopathology, 49, pp. 594-602
Kim, J.Y., Shin, H.J., Kim, T.H., Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer (2006) J Cancer Res Clin Oncol, 132, pp. 302-308
Chiche, J., Ilc, K., Laferrière, J., Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH (2009) Cancer Res, 69, pp. 358-368
Haapasalo, J., Hilvo, M., Nordfors, K., Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas (2008) Neuro Oncol, 10, pp. 131-138
Hsieh, M.J., Chen, K.S., Chiou, H.L., Hsieh, Y.S., Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway (2010) Eur J Cell Biol, 89, pp. 598-606
Kivela, A.J., Parkkila, S., Saarnio, J., Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours (2000) Histochem Cell Biol, 114, pp. 197-204
Kivela, A., Parkkila, S., Saarnio, J., Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors (2000) Am J Pathol, 156, pp. 577-584
Ilie, M.I., Hofman, V., Ortholan, C., Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis (2011) Int J Cancer, 128, pp. 1614-1623
Karhumaa, P., Parkkila, S., Türeci, O., Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium (2000) Mol Hum Reprod, 6, pp. 68-74
Parkkila, S., Parkkila, A.K., Saarnio, J., Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors (2000) J Histochem Cytochem, 48, pp. 1601-1608
Liao, S.Y., Ivanov, S., Ivanova, A., Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: Overexpression of CA12 (CAXII) in glaucoma (2003) J Med Genet, 40, pp. 257-261
Hussain, S.A., Ganesan, R., Reynolds, G., Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer (2007) Br J Cancer, 96, pp. 104-109
Whittington, D.A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci USA, 98, pp. 9545-9550
Svastová, E., Huĺková, A., Rafajová, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Cecchi, A., Hulikova, A., Pastorek, J., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J Med Chem, 48, pp. 4834-4841
Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Modulation of carbonic anhydrase activity and its applications in therapy (2004) Expert Opin Ther Pat, 14, pp. 667-702
Supuran, C.T., Scozzafava, A., Casini, A., Carbonic anhydrase inhibitors (2003) Med Res Rev, 23, pp. 146-189
Pastorekova, S., Casini, A., Scozzafava, A., Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg Med Chem Lett, 14, pp. 869-873
Thiry, A., Dogné, J.-M., Masereel, B., Supuran, C.T., Targeting tumor-associated carbonic anhydrase IX in cancer therapy (2006) Trends Pharmacol Sci, 27, pp. 566-573
Carta, F., Scozzafava, A., Supuran, C.T., Sulfonamides: A patent review 2008-2012 (2012) Expert Opin Ther Pat, 22, pp. 747-758
(2011) Carbonic Anhydrase Inhibitors, , Univ Firenze, Uni Oslo, Univ Manchester et al. WO098610
Masereel, B., Frederick, R., Supuran, C.T., (2012) Tetraline Sulfonamide Derivatives for Use in the Treatment of Proliferative Disorders, , Univ Notre Dame de la Paix WO175654
Casey, J.R., Morgan, P.E., Vullo, D., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J Med Chem, 47, pp. 2337-2347
Scozzafava, A., Briganti, F., Ilies, M.A., Supuran, C.T., Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes (2000) J Med Chem, 43, pp. 292-300
(2008) CA IX-specific Inhibitors, , Institute of Virology of the Slovak Academy of Sciences US095707
Scozzafava, A., (2012) CA IX-specific Inhibitors, , Institute of Virology Supuran CT AU211499
Supuran, C., Scozzafava, A., (2010) CA IX-specific Inhibitors, , Institute of Virology AU200368
Dubois, L., Douma, K., Supuran, C.T., Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors (2007) Radiother Oncol, 83, pp. 367-373
Dubois, L., Lieuwes, N.G., Maresca, A., Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model (2009) Radiother Oncol, 92, pp. 423-428
(2008) Sulfonamide Derivatives Having Carbonic Anhydrase Inhibiting Activity and Their Use As Therapeutic and Diagnostic Agents, , Union Life Sciences Ltd US138291
Pacchiano, F., Aggarwal, M., Avvaru, B.S., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted- ureidobenzenesulfonamides and correlate to inhibitor potency (2010) Chem Commun (Camb, 46, pp. 8371-8373
Pacchiano, F., Carta, F., McDonald, P.C., Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis (2011) J Med Chem, 54, pp. 1896-1902
Supuran, C., Dedhar, S., (2012) Novel Sulfonamide Compounds for Inhibition of Metastatic Tumor Growth, , MetaSignal Therapeutics Inc WO021963
Maresca, A., Temperini, C., Vu, H., Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors (2009) J Am Chem Soc, 131, pp. 3057-3062
Maresca, A., Scozzafava, A., Supuran, C.T., 7,8-disubstituted-but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones i and II in the low nanomolar/subnanomolar range (2010) Bioorg Med Chem Lett, 20, pp. 7255-7258
Lou, Y., McDonald, P.C., Oloumi, A., Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res, 71, pp. 3364-3376
Lock, F.E., McDonald, P.C., Lou, Y., Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche (2012) Oncogene, , doi: 10.1038/onc.2012.550
Vu, H., Pham, N.B., Quinn, R.J., Direct screening of natural product extracts using mass spectrometry (2008) J Biomol Screen, 13, pp. 265-275
Maresca, A., Supuran, C.T., Coumarins incorporating hydroxy-and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones i and II (2010) Bioorg Med Chem Lett, 20, pp. 4511-4514
Supuran, C.T., Parkkila, S., (2010) Treatment of Mammalian Disorders Mediated by Alpha-carbonic Anhydrase Isoforms, , Univ Tampere WO139678
Parkkila, S., Innocenti, A., Kallio, H., The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms (2009) Bioorg Med Chem Lett, 19, pp. 4102-4106
(2012) Composition and Methods for Loop Diuretics with Consistent Bioavailability, , Univ Brown US0053156
Feldman, D.L., Webb, R.L., (2012) Pharmaceutical Composition Comprising A Renin Inhibitor Calcium Channel Blocker and A Diuretic, , US0071470
(2011) Combination of Dronedarone with at Least One Diuretic and Therapeutic Use Thereof, , Sanofi Aventis US0136899
Woo, S.H., (2009) Controlling Body Fluid Condition Using Diuretics, , WO029899
(2011) Pharmaceutical Dosage Form Comprising Nifedipine or Nisoldipine and An Angiotensin-II Antagonist And/or A Diuretic, , Bayer Schering Pharma Ag MX005023
Dillaha, L., Schutter, E., (2010) Alpha-2-Adrenergic Agonists and Angiotensin II Receptor Antagonist Composition, , Sciele Pharma Inc WO065489
Talwar, N., Sebastian, D., Philip, M., (2011) A Stable Pharmaceutical Formulation Comprising Telmisartan and Hydrochlorothiazide, , Pharmascience Inc WO147026
Supuran, C.T., Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides (2008) Curr Pharm des, 14, pp. 641-648
Lee, H.S., Bae, T., Lee, J.H., Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug (2012) BMC Syst Biol, pp. 6-80
Pastorekova, S., Parkkila, S., Zavada, J., Tumor-associated carbonic anhydrases and their clinical significance (2006) Adv Clin Chem, 42, pp. 167-216
Battke, C., Kremmer, E., Mysliwietz, J., Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII (2011) Cancer Immunol Immunother, 60, pp. 649-658
Anticancer carbonic anhydrase inhibitors: A patent review (2008-2013)